Literature DB >> 3837844

Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene.

W M Lee, M Schwab, D Westaway, H E Varmus.   

Abstract

We studied the effect of altered c-myc structure and expression upon the ability of c-myc to promote the transformation of normal rat embryo cells when it was supplemented by EJras (the mutant c-H-ras1 gene from EJ/T24 bladder carcinoma cells). We tested several c-myc alleles cloned from normal and tumor tissues of chicken and human origin and found that only LL4myc (derived from a bursal lymphoma in which an avian leukosis virus long terminal repeat resides within the first c-myc intron in the same transcriptional orientation) had cotransforming activity. No activity was observed with normal chicken and human c-myc alleles, two other bursal lymphoma c-myc alleles (LL3myc and LL6myc), and two human c-myc genes (HSRmyc and DMmyc) from human neuroectodermal tumor cell line COLO320, in which c-myc is amplified. Some of these inactive alleles had the following alterations that are frequently found in tumor-derived c-myc: point mutations affecting the encoded protein (LL3myc); a truncated structure with loss of the first, noncoding exon (LL3myc and DMmyc); and proviral integration within or near the myc locus (LL3myc and LL6myc). The following two experimental approaches indicated that cotransforming activity was directly related to the transcriptional activity of the alleles in cultured rat cells: when cotransfected into Rat-2 cells, LL4myc was more highly expressed than the other (inactive) alleles; and augmented expression of HSRmyc, DMmyc, or normal human or normal chicken c-myc placed under the transcriptional control of retroviral long terminal repeats or increased expression of normal human c-myc under the influence of a retroviral enhancer element was accompanied by cotransformation activity. We concluded that augmented expression of even a normal c-myc gene is sufficient for cotransforming activity and that additional structural alterations frequently found in tumor-derived alleles are neither necessary nor sufficient for the gene to acquire rat embryo cell cotransforming properties.

Entities:  

Mesh:

Year:  1985        PMID: 3837844      PMCID: PMC369162          DOI: 10.1128/mcb.5.12.3345-3356.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.

Authors:  W S Hayward; B G Neel; S M Astrin
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

2.  Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma.

Authors:  K Alitalo; M Schwab; C C Lin; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

3.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

4.  Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene.

Authors:  D J Jolly; A C Esty; S Subramani; T Friedmann; I M Verma
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

5.  Molecular cloning and nucleotide sequence of a transforming gene detected by transfection of chicken B-cell lymphoma DNA.

Authors:  G Goubin; D S Goldman; J Luce; P E Neiman; G M Cooper
Journal:  Nature       Date:  1983-03-10       Impact factor: 49.962

6.  Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.

Authors:  J M Adams; S Gerondakis; E Webb; L M Corcoran; S Cory
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

7.  Human beta-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei.

Authors:  M R Green; T Maniatis; D A Melton
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia.

Authors:  K B Marcu; L J Harris; L W Stanton; J Erikson; R Watt; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.

Authors:  M Schwab; K Alitalo; H E Varmus; J M Bishop; D George
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

10.  Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas.

Authors:  L W Stanton; R Watt; K B Marcu
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

View more
  40 in total

1.  Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers.

Authors:  V Y Hua; W K Wang; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.

Authors:  M D Sklar; E Thompson; M J Welsh; M Liebert; J Harney; H B Grossman; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

4.  In vitro mRNA degradation system to study the virion host shutoff function of herpes simplex virus.

Authors:  C R Krikorian; G S Read
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

5.  Identification of the human c-myc protein nuclear translocation signal.

Authors:  C V Dang; W M Lee
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  Absence of missense mutations in activated c-myc genes in avian leukosis virus-induced B-cell lymphomas.

Authors:  M Hahn; W S Hayward
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

Review 7.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

8.  DNA-binding domain of human c-Myc produced in Escherichia coli.

Authors:  C V Dang; H van Dam; M Buckmire; W M Lee
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

9.  Rearrangement at the 5' end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription.

Authors:  M Schwab; K H Klempnauer; K Alitalo; H Varmus; M Bishop
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

10.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.